Business News • PR NewsWire • Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis

Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis

Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis

ST. PAUL, Minn., Aug. 5, 2019 /PRNewswire/ -- Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other infections caused by herpes simplex viruses, today announced positive results from a Phase 2...

View More : https://www.prnewswire.com:443/news-releases/squarex-announces-positive-results-from-completed-phase-2-study-of-sqx770-i...

Releted News by prnewswire

Saildrone feiert erste unbemannte Umrundung der Antarktis

Porsche Carbon Offsetting Now Just a Click Away for U.S. Drivers

La plataforma de compra de realidad aumentada Point & Place® añade sindicación WebAR

Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis

Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery